(HealthDay)—The CYP3A7*1C allele appears to be associated with mortality and disease progression in specific cancers, according to a study published online March 10 in Cancer Research.
Mar 11, 2016
0
2
A high ratio of two types of immune system cell is linked to an increased risk of disease recurrence after a diagnosis of early stage breast cancer, finds the first study of its kind, published on the eve of international ...
Mar 7, 2016
0
12
(HealthDay)—Chronic pulmonary silicone embolism related to saline breast implants has been detailed in a letter to the editor published in the January issue of the Annals of the American Thoracic Society.
Jan 11, 2016
0
7
In cancer, cell signaling pathways are the critical chain of events that can either quash or quicken disease progression.
Jan 11, 2016
0
74
Boston-A gene that plays a role in the development of breast cancer to metastatic disease has been identified which may help to predict disease progression and serve as a target for the development of future breast cancer ...
Jan 7, 2016
0
20
Postmenopausal women with periodontal disease were more likely to develop breast cancer than women who did not have the chronic inflammatory disease. A history of smoking significantly affected the women's risk.
Dec 21, 2015
0
9
Many are aware that hair loss is a common side effect associated with chemotherapy. However, another albeit common late side effect of cancer treatment is the abnormal swelling of one or more limbs, known as lymphedema. Lymphedema ...
Dec 18, 2015
0
1
Among patients with HER2-positive, metastatic breast cancer that had progressed despite treatment with two or more forms of HER2-targeted therapy (trastuzumab [Herceptin] and lapatinib [Tykerb]), median overall survival was ...
Dec 11, 2015
0
0
Treatment with the chemotherapy agent capecitabine increased disease-free survival for women with HER2-negative breast cancer that was not eliminated by presurgery chemotherapy, according to results from the phase III CREATE-X ...
Dec 9, 2015
0
0
An ongoing phase IIR/III clinical trial presented at the 2015 San Antonio Breast Cancer Symposium seeks to answer an important question in the treatment of early metastatic breast cancer: Should surgery or stereotactic body ...
Dec 8, 2015
0
36
